BIO
John McIntyre
Senior Consultant, Regulatory Strategy Consulting
John has been working in regulatory affairs and clinical development for over 15 years with particular expertise in European regulatory procedures including orphan drug designation, paediatric investigation plans, scientific advice, and PRIME designation.
Prior to joining Parexel in 2019, John worked with a boutique regulatory consultancy and served as a deputy QPPV. His previous experience includes ICON plc working in investigator training and site solutions, as well as earlier experience as a medical and technical writer.
John graduated from the National University of Ireland, Galway top of his class with a bachelor’s degree (first class Hons) in biotechnology. He subsequently earned a PhD in biochemistry and genetics from Cancer Research UK and University College London.